Literature DB >> 31316206

Intestinal infection triggers Parkinson's disease-like symptoms in Pink1-/- mice.

Diana Matheoud1,2, Tyler Cannon3, Aurore Voisin4, Anna-Maija Penttinen4, Lauriane Ramet4, Ahmed M Fahmy1, Charles Ducrot4, Annie Laplante1, Marie-Josée Bourque4, Lei Zhu3, Romain Cayrol1, Armelle Le Campion5, Heidi M McBride6, Samantha Gruenheid7, Louis-Eric Trudeau8, Michel Desjardins9.   

Abstract

Parkinson's disease is a neurodegenerative disorder with motor symptoms linked to the loss of dopaminergic neurons in the substantia nigra compacta. Although the mechanisms that trigger the loss of dopaminergic neurons are unclear, mitochondrial dysfunction and inflammation are thought to have key roles1,2. An early-onset form of Parkinson's disease is associated with mutations in the PINK1 kinase and PRKN ubiquitin ligase genes3. PINK1 and Parkin (encoded by PRKN) are involved in the clearance of damaged mitochondria in cultured cells4, but recent evidence obtained using knockout and knockin mouse models have led to contradictory results regarding the contributions of PINK1 and Parkin to mitophagy in vivo5-8. It has previously been shown that PINK1 and Parkin have a key role in adaptive immunity by repressing presentation of mitochondrial antigens9, which suggests that autoimmune mechanisms participate in the aetiology of Parkinson's disease. Here we show that intestinal infection with Gram-negative bacteria in Pink1-/- mice engages mitochondrial antigen presentation and autoimmune mechanisms that elicit the establishment of cytotoxic mitochondria-specific CD8+ T cells in the periphery and in the brain. Notably, these mice show a sharp decrease in the density of dopaminergic axonal varicosities in the striatum and are affected by motor impairment that is reversed after treatment with L-DOPA. These data support the idea that PINK1 is a repressor of the immune system, and provide a pathophysiological model in which intestinal infection acts as a triggering event in Parkinson's disease, which highlights the relevance of the gut-brain axis in the disease10.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31316206     DOI: 10.1038/s41586-019-1405-y

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  27 in total

Review 1.  Genetics of Parkinson disease: paradigm shifts and future prospects.

Authors:  Matthew James Farrer
Journal:  Nat Rev Genet       Date:  2006-04       Impact factor: 53.242

Review 2.  Loss-of-function rodent models for parkin and PINK1.

Authors:  Marusela Oliveras-Salvá; Anne-Sophie Van Rompuy; Bavo Heeman; Chris Van den Haute; Veerle Baekelandt
Journal:  J Parkinsons Dis       Date:  2011       Impact factor: 5.568

3.  [27th meeting of the Japan Society for Cancer Therapy. 25-27 October 1989, Nagoya. Abstracts].

Authors: 
Journal:  Nihon Gan Chiryo Gakkai Shi       Date:  1989-09-01

4.  Parkin-independent mitophagy requires Drp1 and maintains the integrity of mammalian heart and brain.

Authors:  Yusuke Kageyama; Masahiko Hoshijima; Kinya Seo; Djahida Bedja; Polina Sysa-Shah; Shaida A Andrabi; Weiran Chen; Ahmet Höke; Valina L Dawson; Ted M Dawson; Kathleen Gabrielson; David A Kass; Miho Iijima; Hiromi Sesaki
Journal:  EMBO J       Date:  2014-10-27       Impact factor: 11.598

Review 5.  Triggers, Facilitators, and Aggravators: Redefining Parkinson's Disease Pathogenesis.

Authors:  Michaela E Johnson; Benjamin Stecher; Viviane Labrie; Lena Brundin; Patrik Brundin
Journal:  Trends Neurosci       Date:  2018-10-17       Impact factor: 13.837

Review 6.  The role of innate and adaptive immunity in Parkinson's disease.

Authors:  George T Kannarkat; Jeremy M Boss; Malú G Tansey
Journal:  J Parkinsons Dis       Date:  2013       Impact factor: 5.568

7.  Loss of iron triggers PINK1/Parkin-independent mitophagy.

Authors:  George F G Allen; Rachel Toth; John James; Ian G Ganley
Journal:  EMBO Rep       Date:  2013-11-01       Impact factor: 8.807

8.  The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?

Authors:  Madelyn C Houser; Malú G Tansey
Journal:  NPJ Parkinsons Dis       Date:  2017-01-11

9.  Phosphorylation of Parkin at serine 65 is essential for its activation in vivo.

Authors:  Thomas G McWilliams; Erica Barini; Risto Pohjolan-Pirhonen; Simon P Brooks; François Singh; Sophie Burel; Kristin Balk; Atul Kumar; Lambert Montava-Garriga; Alan R Prescott; Sidi Mohamed Hassoun; François Mouton-Liger; Graeme Ball; Rachel Hills; Axel Knebel; Ayse Ulusoy; Donato A Di Monte; Jevgenia Tamjar; Odetta Antico; Kyle Fears; Laura Smith; Riccardo Brambilla; Eino Palin; Miko Valori; Johanna Eerola-Rautio; Pentti Tienari; Olga Corti; Stephen B Dunnett; Ian G Ganley; Anu Suomalainen; Miratul M K Muqit
Journal:  Open Biol       Date:  2018-11-07       Impact factor: 6.411

10.  Basal Mitophagy Occurs Independently of PINK1 in Mouse Tissues of High Metabolic Demand.

Authors:  Thomas G McWilliams; Alan R Prescott; Lambert Montava-Garriga; Graeme Ball; François Singh; Erica Barini; Miratul M K Muqit; Simon P Brooks; Ian G Ganley
Journal:  Cell Metab       Date:  2018-01-11       Impact factor: 27.287

View more
  101 in total

1.  Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.

Authors:  Zachary D Wallen; Mary Appah; Marissa N Dean; Cheryl L Sesler; Stewart A Factor; Eric Molho; Cyrus P Zabetian; David G Standaert; Haydeh Payami
Journal:  NPJ Parkinsons Dis       Date:  2020-06-12

Review 2.  Microglial memory of early life stress and inflammation: Susceptibility to neurodegeneration in adulthood.

Authors:  Paula Desplats; Ashley M Gutierrez; Marta C Antonelli; Martin G Frasch
Journal:  Neurosci Biobehav Rev       Date:  2019-11-05       Impact factor: 8.989

3.  Chemical inhibition of FBXO7 reduces inflammation and confers neuroprotection by stabilizing the mitochondrial kinase PINK1.

Authors:  Yuan Liu; Travis B Lear; Manish Verma; Kent Zq Wang; P Anthony Otero; Alison C McKelvey; Sarah R Dunn; Erin Steer; Nicholas W Bateman; Christine Wu; Yu Jiang; Nathaniel M Weathington; Mauricio Rojas; Charleen T Chu; Bill B Chen; Rama K Mallampalli
Journal:  JCI Insight       Date:  2020-06-04

Review 4.  Is Gut Dysbiosis an Epicenter of Parkinson's Disease?

Authors:  Charul Rajput; Alika Sarkar; Nidhi Sachan; Neeraj Rawat; Mahendra Pratap Singh
Journal:  Neurochem Res       Date:  2021-01-05       Impact factor: 3.996

5.  TNF receptor-associated factor 6 interacts with ALS-linked misfolded superoxide dismutase 1 and promotes aggregation.

Authors:  Sabrina Semmler; Myriam Gagné; Pranav Garg; Sarah R Pickles; Charlotte Baudouin; Emeline Hamon-Keromen; Laurie Destroismaisons; Yousra Khalfallah; Mathilde Chaineau; Elise Caron; Andrew N Bayne; Jean-François Trempe; Neil R Cashman; Alexandra T Star; Arsalan S Haqqani; Thomas M Durcan; Elizabeth M Meiering; Janice Robertson; Nathalie Grandvaux; Steven S Plotkin; Heidi M McBride; Christine Vande Velde
Journal:  J Biol Chem       Date:  2020-02-06       Impact factor: 5.157

6.  Intragastric Administration of Casein Leads to Nigrostriatal Disease Progressed Accompanied with Persistent Nigrostriatal-Intestinal Inflammation Activited and Intestinal Microbiota-Metabolic Disorders Induced in MPTP Mouse Model of Parkinson's Disease.

Authors:  Xinrong Liu; Shuya Liu; Yong Tang; Zhengjia Pu; Hong Xiao; Jieying Gao; Qi Yin; Yan Jia; Qunhua Bai
Journal:  Neurochem Res       Date:  2021-03-15       Impact factor: 3.996

Review 7.  The gut microbiota-brain axis in behaviour and brain disorders.

Authors:  Livia H Morais; Henry L Schreiber; Sarkis K Mazmanian
Journal:  Nat Rev Microbiol       Date:  2020-10-22       Impact factor: 60.633

Review 8.  Mitochondrial division, fusion and degradation.

Authors:  Daisuke Murata; Kenta Arai; Miho Iijima; Hiromi Sesaki
Journal:  J Biochem       Date:  2020-03-01       Impact factor: 3.387

Review 9.  Innate and adaptive immune responses in Parkinson's disease.

Authors:  Aubrey M Schonhoff; Gregory P Williams; Zachary D Wallen; David G Standaert; Ashley S Harms
Journal:  Prog Brain Res       Date:  2019-12-05       Impact factor: 2.453

10.  Overcoming blood-brain barrier transport: Advances in nanoparticle-based drug delivery strategies.

Authors:  Shichao Ding; Aminul Islam Khan; Xiaoli Cai; Yang Song; Zhaoyuan Lyu; Dan Du; Prashanta Dutta; Yuehe Lin
Journal:  Mater Today (Kidlington)       Date:  2020-03-04       Impact factor: 31.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.